CNO Financial Group

CNO · NYSE

$54.86+$0.79 (+1.46%)TodayMarket closed · Oct 20, 7:31 PM ET

Prev close $54.07

CNO analyst rating

HoldConsensus of 4 analysts over the last 12 months. 25% rate it a buy.

Strong buy0
Buy1
Hold3
Underperform0
Sell0

12-month price target · 6 analysts

Average $58.96 (+7.5% upside)

Low: $52.52
Now: $54.86
High: $73.50

Upgrades and downgrades

The latest rating actions, newest first

CNO analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Keefe, Bruyette & Woods	Aug 3, 2026	Maintains	Market Perform	$53.00 → $57.00	71%
Evercore ISI Group	Aug 3, 2026	Maintains	In-Line	$52.00 → $54.00	59%
Evercore ISI Group	Jul 13, 2026	Maintains	In-Line	$48.00 → $52.00	59%
Keefe, Bruyette & Woods	Jul 13, 2026	Maintains	Market Perform	$50.00 → $53.00	71%
Jefferies	Jul 10, 2026	Downgrade	Buy → Hold	$53.00 → $55.00	76%
Evercore ISI Group	Jun 1, 2026	Upgrade	Underperform → In-Line	$43.00 → $48.00	59%
Keefe, Bruyette & Woods	May 5, 2026	Maintains	Market Perform	$46.00 → $50.00	71%
Keefe, Bruyette & Woods	Mar 26, 2026	Initiates	Market Perform	$46.00	71%
Evercore ISI Group	Feb 18, 2026	Maintains	Underperform	$42.00 → $43.00	59%
Piper Sandler	Dec 23, 2025	Maintains	Overweight	$46.00 → $50.00	64%

The case for and against

Updated Jul 31, 2025

Bull case

CNO Financial Group Inc. exhibited a positive financial trajectory, with life policy income increasing 3.2% year-over-year to $226.5 million, aligning closely with estimates, while overall policy income rose 2.7% to $409.4 million, surpassing forecasts. The company also demonstrated robust growth in its agent count, rising 8.3% year-over-year to 4,952, indicating effective agent recruitment and retention strategies. Additionally, the investment portfolio's book yield improved, reaching 4.87%, alongside a notable increase in collected annuity premiums, which amounted to $493.1 million, reflecting a growing demand for its annuity products.

Bear case

CNO Financial Group's outlook has been negatively impacted by several key financial metrics indicating potential weakness in its performance. The RBC ratio declined slightly to 383%, and there is an expectation of continued declines in fee income for the second consecutive year, primarily due to a shift towards smaller Medicare Advantage providers. Additionally, both the annuity profitability and supplemental health margins have weakened on a year-over-year basis, while the holding company's liquidity decreased to $372 million, further heightening concerns about its financial stability and growth prospects.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.